Association of monocyte-lymphocyte ratio and proliferative diabetic retinopathy in the U.S. population with type 2 diabetes.
Wang H, Guo Z, Xu Y.
J Transl Med. 2022 May 13;20(1):219. doi: 10.1186/s12967-022-03425-4.
PMID:35562757
Proliferative diabetic retinopathy as onset of type 1 diabetes.
Basurto A, Cicinelli MV, Lattanzio R, Bandello F.
Can J Ophthalmol. 2020 Jun;55(3):e92-e95. doi: 10.1016/j.jcjo.2019.09.006. Epub 2019 Dec 19.
PMID:31866090
Functional and structural outcomes and complications after pars plana vitrectomy for severe features of proliferative diabetic retinopathy in type 1 and type 2 diabetes mellitus.
Kaźmierczak K, Żuchowski P, Stafiej J, Malukiewicz G.
Relationship between Proliferative Diabetic Retinopathy and Inflammatory Markers in Patients with Type 1 Diabetes in Brazil: A Nested Case Control Study.
Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus - A comparative observational study.
Kumar K, Baliga G, Babu N, Rajan RP, Kumar G, Mishra C, Chitra R, Ramasamy K.
Indian J Ophthalmol. 2021 Nov;69(11):3289-3295. doi: 10.4103/ijo.IJO_1293_21.
PMID:34708790
Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients.
Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW; DPV-Wiss Study Group.
Diabetologia. 2011 Aug;54(8):1977-84. doi: 10.1007/s00125-011-2198-1. Epub 2011 Jun 3.
PMID:21638132
Fenofibrate for diabetic retinopathy.
Kataoka SY, Lois N, Kawano S, Kataoka Y, Inoue K, Watanabe N.
Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2.
PMID:37310870
Prevalence of Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland.
Matuszewski W, Baranowska-Jurkun A, Stefanowicz-Rutkowska MM, Modzelewski R, Pieczyński J, Bandurska-Stankiewicz E.